Protein misfolding is at the root of several genetic human diseases. These
diseases do not stem from mutations within the active domain of the protein
s, but from mutations that disrupt their three-dimensional conformation, wh
ich leads to their intracellular retention by the quality control apparatus
of the cell. Facilitating the escape of the mutant proteins from the quali
ty control system by lowering the temperature of the cells or by adding che
micals that assist folding (chemical chaperones) can result in proteins tha
t are fully functional despite their mutation. The discovery that ligands w
ith pharmacological selectivity (pharmacological chaperones) can rescue the
proper targeting and function of misfolded proteins, including receptors,
might help to develop new treatments for 'conformational diseases'.